Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :350
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Aprepitant: A substance P antagonist for chemotherapy induced nausea and vomiting

Girish C, Manikandan S

Year : 2007| Volume: 44| Issue : 1 | Page no: 25-30

   This article has been cited by
 
1 Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
Michelle C Janelsins,Mohamedtaki A Tejani,Charles Kamen,Anita R Peoples,Karen M Mustian,Gary R Morrow
Expert Opinion on Pharmacotherapy. 2013; 14(6): 757
[Pubmed]  [Google Scholar] [DOI]
2 Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
Janelsins, M.C. and Tejani, M.A. and Kamen, C. and Peoples, A.R. and Mustian, K.M. and Morrow, G.R.
Expert Opinion on Pharmacotherapy. 2013; 14(6): 757-766
[Pubmed]  [Google Scholar]
3 Use of high-dose cisplatin with aprepitant in an outpatient setting
Furukawa, N. and Kawaguchi, R. and Kobayashi, H.
European Journal of Cancer Care. 2012; 21(4): 436-441
[Pubmed]  [Google Scholar]
4 Ondansetron in combination with gingerol suppresses cisplatin-induced pica in rats
Yang, Y.-L. and Yue, W. and Tian, Z.-B. and Wang, M.-L. and Yang, Z.-H. and Zhang, Q. and Wei, L.-Z. and Zhao, Q.-X. and Shi, Z.-Y.
World Chinese Journal of Digestology. 2011; 19(10): 1034-1039
[Pubmed]  [Google Scholar]
5 Use of high-dose cisplatin with aprepitant in an outpatient setting : Management of high-dose cisplatin administration
N. FURUKAWA, R. KAWAGUCHI, H. KOBAYASHI
European Journal of Cancer Care. 2011; : no
[HTML Full text]  [Google Scholar] [DOI]
6 Chemotherapy-Induced Nausea and Vomiting: Challenges and Opportunities for Improved Patient Outcomes
Hawkins, R. and Grunberg, S.
Clinical Journal of Oncology Nursing. 2009; 13(1): 54-64
[Pubmed]  [Google Scholar]
7 Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer
Cefalo, M.G., Ruggiero, A., Maurizi, P., Attiną, G., Arlotta, A., Riccardi, R.
Journal of Chemotherapy. 2009; 21(6): 605-610
[Pubmed]  [Google Scholar]
8 Pharmacological Characterization of T-2328, 2-Fluoro-4ę-methoxy-3ę-[[[(2S, 3S)-2-phenyl-3-piperidinyl] amino] methyl]-[1, 1ę-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK 1 Receptor
Watanabe, Y. and Asai, H. and Ishii, T. and Kiuchi, S. and Okamoto, M. and Taniguchi, H. and Nagasaki, M. and Saito, A.
Journal of Pharmacological Sciences. 2008; 106(1): 121-127
[Pubmed]  [Google Scholar]
9 Aprepitant - Where do we stand in the control of chemotherapy-induced nausea and vomiting?
Sarcev, T., Secen, N., Zaric, B., Milovancev, A.
Journal of B.U.ON.. 2008; 13(3): 333-339
[Pubmed]  [Google Scholar]
10 Substance P and its receptors--a potential target for novel medicines in malignant brain tumour therapies (mini-review)
Neuropeptides, M. and Warsaw, P., Łazarczyk, M., Matyja, E., Lipkowski, A.
Folia Neuropathologica. 2007; 45(3): 99-107
[Pubmed]  [Google Scholar]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow